SID 2026Abstract 1025
AB102 is a potent and orally bioavailable small molecule inhibitor of MRGPRX2
Serwas NK, Zhang L, Nathaniel D, Mitchell C, Opoku-Temeng C, Thomas J, Dhanju S, Lamani M, Nareddy P, Corbin J, Kattamuri V, Yadav M, Foley C, Sharif EU, Leleti MR, Walters MJ, Sivick KE, Falahati R
SID Annual Meeting 2026Preclinical studiesChicago, 13–16 May 2026 · published in JID 21 Jul 2026
Topics: JAK inhibitors & other targeted pills
Abstract
The abstract’s text is on the JID website.
DOI 10.1016/j.jid.2026.06.1056 · Not in PubMed: details from Crossref